Outcomes are clinical and surgical of brain tumors in Iraqi patients

Abstract

Author(s): Mohammed Rashad Ismael Al-Jawaheri, Ammar Saeed Rashid, Saadoun Mohsin Saadoun, Salim Mardan Omer, Ali Qais Abdulkafi

Background: The survival rates of patients with brain tumours have significantly improved over the last few decades. Objective: This paper aims to study the clinical and surgical findings in Iraqi patients with brain tumours. Patients and methods: A cross-sectional study was undertaken on the medical records of brain tumour patients admitted for treatment at hospitals in different in Iraq between 17th March 2022 and 20th January 2023. Our clinical methodology was designed to capture the demographic characteristics of 84 patients with brain tumours. General anaesthesia was administered to patients undergoing brain tumour surgery. The methodology was constructed by analysing the collected data with the aid of SPSS.22.0 and Excel 2016. The basic characteristics were identified through the utilization of calculated percentages and frequencies alongside mean ± SD to present the univariate analysis. Results and discussion: Based on clinical demographics, our investigation reveals that the number of male patients' cases was more significant, with 54 (64.29%) cases in comparison to 30 (35.71%) cases in females. Furthermore, the research revealed a rise in the proportion of patients with non-glioma at 48 (57.14%) in comparison with gliomas at 36 (42.86%). Our study determined infection as the highest contributing factor at 10 (11.9%), while neurological deficits were the lowest factor at 3 (3.57%). As a result, our analysis revealed a median survival time of 12.12 months and a survival rate of 49.7%. Conclusion: our study revealed that glioma treatment can significantly impact the survival rates of patients diagnosed with brain tumors. It was observed that patients' survival rates varied depending on the type of treatment they received.

Share this article